The emerging approach of this peptide represents a exciting advance in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide146188.pages10.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-77465010